Cell biology:
3D Cell Culture:- developments in technology to improve in vitro analyses.

Biologics:
Balancing a biologics pipeline portfolio Why biosuperiors represent a solid counterbalance to an innovative research and development programme.

Drug Development:
 The benefits of drug repositioning.

Epigenetics:
Epigenetics an emerging target class for drug screening.

Molecular Diagnostics:
 The future of molecular diagnostics for cancer: a ‘personalised’ perspective.

Genomics:
The post genomics era: what does it all mean and how can we translate it?


Therapeutics:
 Regenerative medicine: a paradigm shift in healthcare.


Drug Development:
Enabling the promise of STEM CELLS.